Posts Tagged ‘schar’
Lung cancer screening at Saville Center: Less time, less worry for patients
Amit Mahajan, MD is board certified in pulmonary disease and critical care medicine. He serves as the medical director of interventional pulmonology and the complex airways disease program at Inova Fairfax Medical Campus. Lung cancer screening takes time. And that time often turns into stress for patients and their loved ones. That’s one reason that…
Read MoreFighting a Cancer Epidemic With a Vaccine
John Deeken, MD, is president of the Inova Schar Cancer Institute. He is board-certified in medical oncology and specializes in head and neck cancers. Quitting smoking. Eating better. Wearing sunscreen. These are all well-known behaviors that can lower cancer risk. But there’s another, less-heralded way to reduce cancer odds: get vaccinated. Specifically, vaccination against the…
Read MoreFDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial
Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…
Read MoreFrom Research to Results: Advances in Genitourinary Cancer Treatment
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. This February, I’ll be traveling to…
Read More